-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kristijan H. Kahler, SM

Articles by Kristijan H. Kahler, SM

Tegaserod Treatment for IBS: A Model of Indirect Costs

ByDean G. Smith, PhD,Victoria Barghout, MSPH,Kristijan H. Kahler, SM

April 15th 2005

Effectiveness of Tegaserod Therapy on GI-related Resource Utilization in a Managed Care Population

ByJudith J. Stephenson, SM,Victoria Barghout, MSPH,Kristijan H. Kahler, SM,Joaquim Fernandes, BA,Jane F. Beaulieu, MSN,Samuel Joo, MS,Stephen J. Boccuzzi, PhD

April 15th 2005

Budget Impact of Tegaserod on a Managed Care Organization Formulary

ByMichael A. Bloom, BA,Victoria Barghout, MSPH,Kristijan H. Kahler, SM,Judith Bentkover, PhD,Hannah Kurth, BA,Ian M. Gralnek, MD, MSHS,Brennan M. R. Spiegel, MD, MSHS

April 15th 2005

Impairment in Work Productivity and Health-related Quality of Life in Patients With IBS

ByBonnie B. Dean, PhD,Daniel Aguilar, MPH,Victoria Barghout, MSPH,Kristijan H. Kahler, SM,Feride Frech, MPH,David Groves, PhD,Joshua J. Ofman, MD

April 15th 2005

Latest Updated Articles

Tegaserod Treatment for IBS: A Model of Indirect Costs
April 15th 2005
Effectiveness of Tegaserod Therapy on GI-related Resource Utilization in a Managed Care Population
April 15th 2005
Budget Impact of Tegaserod on a Managed Care Organization Formulary
April 15th 2005
Impairment in Work Productivity and Health-related Quality of Life in Patients With IBS
April 15th 2005

Trending on AJMC

Patient Portal Messages Outpace Office Visits

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk